We are live on ! Find out more
CP

CenterBook Partners Portfolio holdings

AUM $1.86B
1-Year Est. Return 24.52%
This Fund
S&P 500
This Quarter Est. Return
+5.22%
1 Year Est. Return
+24.52%
3 Year Est. Return
+37.52%
5 Year Est. Return
10 Year Est. Return
AUM
$1.45B
AUM Growth
+$629M
Cap. Flow
+$577M
Cap. Flow %
39.86%
Top 10 Hldgs %
13.44%
Holding
504
New
126
Increased
196
Reduced
51
Closed
131

Top Sells

Rank Stock Value
1
AES icon
AES
AES
+$7.04M
2
NVDA icon
NVIDIA
NVDA
+$6.76M
3
CVS icon
CVS Health
CVS
+$6.63M
4
KLG
WK Kellogg Co
KLG
+$5.82M
5
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$5.77M

Sector Composition

Rank Sector Weight
1 Technology 25.6%
2 Consumer Discretionary 14.68%
3 Industrials 11.41%
4 Communication Services 10.59%
5 Healthcare 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MHK icon
176
Mohawk Industries
MHK
$7.29B
$3.14M 0.22%
24,017
+3,576
+17% +$402K
AVPT icon
177
AvePoint
AVPT
$2.72B
$3.13M 0.22%
395,053
+261,446
+196% +$2.06M
UNP icon
178
Union Pacific
UNP
$172B
$3.12M 0.22%
+12,678
New +$3.12M
MIRM icon
179
Mirum Pharmaceuticals
MIRM
$6.87B
$3.08M 0.21%
122,457
+70,620
+136% +$1.94M
PFGC icon
180
Performance Food Group
PFGC
$18B
$3.07M 0.21%
41,165
+2,758
+7% +$203K
RTX icon
181
RTX Corp
RTX
$289B
$3.04M 0.21%
31,198
-8,074
-21% -$729K
FTI icon
182
TechnipFMC
FTI
$27.5B
$3.02M 0.21%
+120,262
New +$2.53M
MDT icon
183
Medtronic
MDT
$110B
$3M 0.21%
34,425
+3,349
+11% +$286K
TMO icon
184
Thermo Fisher Scientific
TMO
$214B
$2.95M 0.2%
5,074
+1,378
+37% +$773K
LEA icon
185
Lear
LEA
$7.33B
$2.95M 0.2%
20,354
+15,601
+328% +$2.14M
SHW icon
186
Sherwin-Williams
SHW
$83.7B
$2.95M 0.2%
8,487
+859
+11% +$274K
PAYC icon
187
Paycom
PAYC
$7.53B
$2.84M 0.2%
+14,281
New +$2.73M
VRT icon
188
Vertiv
VRT
$87.6B
$2.83M 0.2%
34,687
-15,303
-31% -$962K
STER
189
DELISTED
Sterling Check Corp. Common Stock
STER
$2.83M 0.2%
176,029
-9,261
-5% -$132K
LPX icon
190
Louisiana-Pacific
LPX
$5.02B
$2.81M 0.19%
33,507
-1,154
-3% -$82.9K
IBKR icon
191
Interactive Brokers
IBKR
$40.3B
$2.79M 0.19%
99,796
+7,208
+8% +$179K
ICE icon
192
Intercontinental Exchange
ICE
$87.7B
$2.78M 0.19%
20,228
+7,801
+63% +$1.04M
WTRG icon
193
Essential Utilities
WTRG
$11.4B
$2.74M 0.19%
73,831
+40,337
+120% +$1.46M
NET icon
194
Cloudflare
NET
$101B
$2.71M 0.19%
+27,998
New +$2.54M
ADM icon
195
Archer Daniels Midland
ADM
$38.9B
$2.68M 0.19%
+42,679
New +$2.51M
AAON icon
196
Aaon
AAON
$7.17B
$2.66M 0.18%
30,237
+1,194
+4% +$93.6K
PII icon
197
Polaris
PII
$3.88B
$2.64M 0.18%
26,348
+10,462
+66% +$961K
BABA icon
198
Alibaba
BABA
$279B
$2.59M 0.18%
+35,726
New +$2.62M
BR icon
199
Broadridge
BR
$17.9B
$2.58M 0.18%
12,618
+4,868
+63% +$982K
HUM icon
200
Humana
HUM
$44B
$2.58M 0.18%
+7,452
New +$2.82M

Similar funds

CenterBook Partners's Q1 2024 Portfolio in Review

As of Q1 2024, CenterBook Partners held 504 positions worth $1.45B, up 77% from $820M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

CenterBook Partners deployed $577M of net new capital in Q1 2024, opening 126 new positions and adding to 196 existing holdings. Its largest new stake was Nutrien: 389,754 shares worth $21.2M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was CVS Health, an estimated $6.63M trimmed.

  • CenterBook Partners's largest Q1 2024 buy was Nutrien: 389,754 shares worth $21.2M.
  • CenterBook Partners added most to Integral Ad Science in Q1 2024, an estimated $21.5M increase.
  • CenterBook Partners's biggest Q1 2024 reduction was CVS Health, cutting an estimated $6.63M.
  • CenterBook Partners fully exited AES in Q1 2024, selling an estimated $7.04M.
  • CenterBook Partners's ten largest holdings make up 13% of its $1.45B portfolio in Q1 2024.
  • CenterBook Partners opened 126 new positions and closed 131 in Q1 2024.
  • CenterBook Partners's portfolio value rose 77% quarter-over-quarter to $1.45B.

Based on CenterBook Partners's 13F filing for Q1 2024, filed 10 May 2024.